IMCC Company Profile and Key Details

IM Cannabis Corp. (NASDAQ:IMCC) closed at $4.23 USD, gaining $2.49 (143.10%) from the previous close of $1.74. The stock is currently mid-range between its 52-week high and low $1.55 and $77.10. With a market capitalization of about $2.55 million, IM Cannabis Corp. is classified as a micro-cap and shows higher-than-market volatility (beta ~2.10). Key stats such as the average daily volume over the past year has been around 107.22 thousand shares, trading with heavier-than-usual volume. Headquartered in Vancouver, BC, IM Cannabis Corp. operates in the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry. Led by CEO Oren Shuster, the company employs approximately 44 people and listed since May 20, 2020. IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada.

Short-term trend indicators are bullishly aligned (SMA20 -32.73%, SMA50 -44.33%, SMA200 -63.66%). The stock’s 14-day RSI is 18.25 (weak momentum), while the ATR of 0.13 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -89.86% below its high and over -5.0% above its low. Average 10-day trading volume of 13.19 million shares is significantly above the 3-month average of 1.76 million, indicating heightened recent market interest.

IM Cannabis Corp. trades at a P/E ratio of -0.17, slightly below the S&P 500 average, with a price-to-sales ratio of 0.09 and a price-to-book ratio of -9.83 indicating negative book value, which may reflect financial stress. The P/FCF stands at -1.49, also below market averages.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

IM Cannabis Corp. generated EPS of -$0.79 over the past year. Five-year average earnings growth is 20.43%. The latest quarter delivered EPS of -$0.86. The next quarter is forecast at $nan. Next year's EPS is expected at $60.66. IM Cannabis Corp. earnings surprise history is frequent misses against expectations. The quarter that ended March 30, 2026, missed forecasts by -1100.47%. The prior quarter beat by 2214.35%. Over the last six quarters, Apple has recorded several small beats. These include -57.14% in November 14, 2024.

IM Cannabis Corp. has 6.09 million shares outstanding. The public float is 2.49 million shares, elevated short interest at 0.06% of float. This equals 2.99 thousand shares. The short ratio is 0.04 days. Institutional investors hold 0.7% of the float. Insiders own 35.15%.

Our AI price prediction model suggests that IM Cannabis Corp. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -45.15%, with price expected at $2.32 by October 02, 2026, within a range of $1.71 to $2.92 3-Month Outlook: Projected fall of -87.94%, reaching $0.51 by December 17, 2026, with a range of $0.00 to $2.24. 1-Year Outlook: Projected loss of -99.29%, with price at $0.03 by September 17, 2027, within a range of $0.00 to $3.72.

IM Cannabis Corp. (NASDAQ:IMCC) shares are flat -5.76% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows IM Cannabis Corp. trading at a premium to the broader market with a P/E of -0.17. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $8.00, suggesting 89.13% upside. Our AI forecast model points to short-term weakness (-45.15% over two weeks), a medium-term fall (-87.94% over three months), and a longer-term loss (-99.29% over one year), with expected trading ranges indicating moderate volatility.